Sio Capital Management, LLC Bicycle Therapeutics PLC Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$19.9 - $26.25 $3.42 Million - $4.51 Million	-171,738 Reduced 17.73%	796,933 $16 Million
Q2 2023 Aug 14, 2023	BUY	$18.95 - $28.67 $25,089 - $37,959	1,324 Added 0.14%	968,671 $24.7 Million
Q1 2023 May 12, 2023	BUY	$20.02 - $31.37 $5.68 Million - $8.91 Million	283,922 Added 41.54%	967,347 $20.6 Million
Q3 2022 Nov 14, 2022	SELL	$17.49 - $28.44 $97,314 - $158,240	-5,564 Reduced 0.81%	683,425 $15.9 Million
Q2 2022 Aug 15, 2022	BUY	$12.95 - $46.99 $8.24 Million - $29.9 Million	636,201 Added 1205.2%	688,989 $11.6 Million

Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $48,625 - $72,114	-1,212 Reduced 2.24%	52,788 $2.32 Million
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $2.25 Million - $3.3 Million	54,000 New	54,000 $3.29 Million

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $581M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.